Global RNA-sequencing of a pediatric AML primary sample treated with Tamibarotene or vehicle
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP275577
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study was to assess the global transcriptional changes in a pediatric AML primary sample treated with Tamibarotene. This patient sample has a retinoic acid receptor alpha (RARA) super-enhancer, which is correlated with higher RARA mRNA levels and increased sensitivity to Tamibarotene in vitro and in vivo (Patient-derived xenograft mouse model). Overall design: There were 4 replicates per treatment condition: Tamibarotene or DMSO (as a control) for the 1 patient sample
创建时间：
2022-06-22
